EN Mobile Logo

Search form


Cardiovascular Health

Cardiovascular Safety of DPP-4 Inhibitors

To address conflicting reports about the cardiovascular safety of DPP-4 inhibitors, researchers performed a large retrospective cohort study.


© Makistock/Shutterstock.com


Cardiovascular Health

How well do waist-to-height ratios calculated using NHANES and WHO protocols indicate cardiometabolic risk in youth with diabetes?

Research has shown the beneficial effects of empagliflozin on all-cause and CV mortality. Does the same hold true for another SGLT2 inhibitor?

Strength training can improve glycemic control among diabetics, but can it reduce rates of type 2 diabetes and cardiovascular disease?

The American Heart Association released a statement about the impact meal timing and frequency has on cardiometabolic health and obesity.

Asking about and treating sexual dysfunction may not only improve a patient’s quality of life, but also address serious health problems down the road.

Further study is needed, but adding fenofibrate to statins may decrease cardiovascular disease events in certain patients with type 2 diabetes.

Past studies have linked nut consumption to decreased risk of CVD & all-cause mortality, but have not systematically evaluated less common causes of death.


Subscribe to Cardiovascular Health on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.